Circulatory c-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo

HIGHLIGHTS

• who: Marina Kashiwagi et al. from the Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Department of Medical Secretarial Arts, Kansai Women`s College, Japan have published the paper: Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo, in the Journal: PLOS ONE of October/20,/2022
• what: The authors analysed the craniofacial morphology of mice with MPS VII and investigated the underlying mechanisms promoting jaw deformities in these animals.
• how: The authors analysed the head and neck morphology of MPS type VII model . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.